Skip to main content

Part of Cancer staging guidance sheets

Colon and rectum (ICD10 C18-C20)

Current Chapter

Current chapter – Colon and rectum (ICD10 C18-C20)


Introduction

This is the data sheet for TNM 9th edition staging of the colon and rectum (ICD10 C18-C20 - excluding C18.1)

For more detailed information regarding TNM staging, please see pages 75-78 of the UICC TNM 9 book.


Stage groupings

Stage Group

T stage

N stage

M stage

Stage 0

Tis

N0

M0

Stage I

T1, T2

N0

M0

Stage II

T3, T4

N0

M0

Stage IIA

T3

N0

M0

Stage IIB

T4a

N0

M0

Stage IIC

T4b

N0

M0

Stage III

Any T

N1, N2

M0

Stage IIIA

T1, T2

N1

M0

 

T1

N2a

M0

Stage IIIB

T1, T2

N2b

M0

 

T2, T3

N2a

M0

 

T3, T4a

N1

M0

Stage IIIC

T3, T4a

N2b

M0

 

T4a

N2a

M0

 

T4b

N1, N2

M0

Stage IV

Any T

Any N

M1

Stage IVA

Any T

Any N

M1a

Stage IVB

Any T

Any N

M1b

Stage IVC

Any T

Any N

M1c


TNM clinical classification

T - primary tumour

T value Description

cTX

Primary tumour cannot be assessed

cT0

No evidence of primary tumour

cTis

Carcinoma in situ: invasion of lamina propriaa

cT1

Tumour invades submucosa

cT2

Tumour invades muscularis propria

cT3

Tumour invades subserosa or into non‐peritonealised pericolic or perirectal tissues

cT4

Tumour directly invades other organs or structuresb,c,d and/or perforates visceral peritoneum

cT4a - Tumour perforates visceral peritoneum

cT4b - Tumour directly invades other organs or structures

Notes

aTis includes cancer cells confined within the mucosal lamina propria (intramucosal) with no extension through the muscularis mucosae into the submucosa.

bInvades through to visceral peritoneum to involve the surface

cDirect invasion in T4b includes invasion of other organs or segments of the colorectum by way of the serosa, as confirmed on microscopic examination, or for tumours in a retroperitoneal or subperitoneal location, direct invasion of other organs or structures by virtue of extension beyond the muscularis propria.

dTumour that is adherent to other organs or structures, macroscopically, is classified cT4b. However, if no tumour is present in the adhesion, microscopically, the classification should be pT1-3, depending on the anatomical depth of wall invasion.

N - regional lymph nodes

N value

Description

cNX

Regional lymph nodes cannot be assessed

cN0

No regional lymph node metastasis

cN1

Metastasis in 1 to 3 regional lymph nodes

cN1a - Metastasis in 1 regional lymph node

cN1b - Metastasis in 2 to 3 regional lymph nodes

cN1c - Tumour deposit(s), i.e. satellites,* in the subserosa, or in non‐peritonealised pericolic or peri-rectal soft tissue without regional lymph node metastasis

cN2

Metastasis in 4 or more regional lymph nodes

cN2a - Metastasis in 4–6 regional lymph nodes

cN2b - Metastasis in 7 or more regional lymph nodes

Notes:

Note * Tumour deposits (TDs) represent discrete tumour nodules of any shape, contour or size in peri-rectal and peri-colonic fat, away from the leading edge of the tumour, within the lymph drainage area of the primary carcinoma. TDs can originate from different histological structures, including lymph nodes, vessels and nerves. Therefore, TDs may contain foci of extramural vascular invasion (EMVI) and perineural invasion (PNI). The feature distinguishing a TD from EMVI and PNI is the presence of unequivocal tumour extension from the vessel or nerve into the surrounding fat or fibroconnective tissue. When tumour outgrowth from EMVI and/or PNI is present, the diagnosis of TDs and EMVI/PNI should be denoted separately in the report. If the tumour involves an identifiable lymph node, it is considered as lymph node metastasis and not as TDs even if the tumour extends into the perinodal fat

M - distant metastasis

M value Description

cM0

No distant metastasis

cM1

Distant metastasis

cM1a - Metastasis confined to one organ (liver, lung, ovary, non‐regional lymph node(s)) without peritoneal metastases

cM1b - Metastasis in more than one organ

cM1c - Metastasis to the peritoneum with or without other organ involvement


TNM pathological classification

pT - primary tumour

The pT and pN categories correspond to the cT and cN categories as per above.

pN - regional lymph nodes

pN value

Description

pN0

Histological examination of a regional lymphadenectomy specimen will ordinarily include 12 or more lymph nodes. If the lymph nodes are negative, but the number ordinarily examined is not met, classify as pN0


Download

Click on the box below to download a PDF version of this staging sheet:

Last edited: 30 January 2026 3:31 pm

  1. Cancer staging guidance sheets
  2. Oral Cavity and mucosal lip (ICD10 C00.3-5, C02-C06)
  3. Malignant melanoma of upper aerodigestive tract (ICD10 C00-06, C09-14, C30-32)
  4. Pharynx (ICD10 C01, C02.4, C05.1-2, C09, C10.0, C10.2-3, C10.9, C11-13)
  5. Salivary glands (ICD10 C00-C14, C15.0, C30-C33, C41.1)
  6. Oesophagus including oesophagogastric junction (ICD10 C15, C16.0)
  7. Gastrointestinal stromal tumours (ICD10 C15-C20, C48.1-2)
  8. Stomach (ICD10 C16 - excluding C16.0)
  9. Small intestine (ICD10 C17)
  10. Appendix (ICD10 C18.1)
  11. Colon and rectum (ICD10 C18-C20)
  12. Anal and perianal skin (ICD10 C21)
  13. Liver (ICD10 C22.0)
  14. Intrahepatic bile ducts (ICD10 C22.1)
  15. Gallbladder (ICD10 C23)
  16. Distal extrahepatic bile duct (ICD10 C24.0)
  17. Perihilar bile ducts (ICD10 C24.0)
  18. Ampulla of vater (ICD10 C24.1)
  19. Pancreas (ICD10 C25)
  20. Nasal cavity and paranasal sinuses (ICD10 C30.0, C31.0, C31.1)
  21. Larynx (ICD10 C32.0, C32.1, C32.2, C10.1)
  22. Lung (ICD10 C34)
  23. Thymus tumours (ICD10 C37.9)
  24. Soft tissues (ICD10 C15-C26, C34-C37 C38.1-3, C47-C49, C51-C53, C58, C60-C68)
  25. Bone (ICD10 C40, C41)
  26. Melanoma of skin (ICD10 C00.0-2, C00.6, C21.2, C43, C51, C60, C63.2)
  27. Merkel cell carcinoma of skin (ICD10 C00, C44, C51, C60, 63.2, C80)
  28. Skin carcinoma of the head and neck (ICD10 C00.0-2, C00.6, C44.0, C44.2-4)
  29. Carcinoma of skin of the eyelid (ICD10 C44.1)
  30. Carcinoma of skin (excluding eyelid, head and neck, perianal, vulva and penis) (ICD10 C44.5-7, C63.2)
  31. Pleural mesothelioma (ICD10 C38.4)
  32. Breast tumours (ICD10 C50)
  33. Vulva (ICD10 C51)
  34. Cervix uteri (ICD10 C53)
  35. Uterine sarcomas
  36. Uterus - endometrium (ICD10 C54.1, C55)
  37. Ovarian, fallopian tube and primary peritoneal carcinoma (ICD10 C56, C57, C48.1, C48.2)
  38. Gestational trophoblastic neoplasms (ICD10 C58)
  39. Penis tumours (ICD10 C60)
  40. Prostate tumours (ICD10 C61.9)
  41. Testis tumours (ICD10 C62)
  42. Kidney tumours (ICD10 C64)
  43. Renal pelvis and ureter tumours (ICD10 C65 & C66)
  44. Urinary bladder tumours (ICD10 C67)
  45. Urethra tumours (ICD10 C68.0, C61.9)
  46. Carcinoma of conjuctiva (ICD10 C69.0)
  47. Melanoma of conjuctiva (ICD10 C69.0)
  48. Retinoblastoma (ICD10 C69.2)
  49. Melanoma of uvea (ICD10 C69.3-4)
  50. Carcinoma of lacrimal gland (ICD10 C69.5)
  51. Sarcoma of orbit (ICD10 C69.6)
  52. Thyroid gland (ICD10 C73.9)
  53. Adrenal cortex (ICD10 C74.0)
  54. Adrenal medulla and extra-adrenal paraganglia (ICD10 C74.1 C75.5)
  55. Parathyroid gland (ICD10 C75.0)
  56. Unknown primary - cervical nodes (ICD10 C77.0)
  57. Mycosis fungoides or sezary syndrome (ICD10 C84.0 and C84.1)
  58. T and B cutaneous lymphoma (ICD10, C82.6, C84.8, C86.6 and other C83-C86 if primary skin excluding C84.0 C84.1)
  59. Rhabdomyosarcoma (CTYA)
  60. Chronic lymphocytic leukaemia
  61. Hepatoblastoma (CTYA)
  62. Hodgkins and non-hodgkins lymphoma (ICD10 C81-88)
  63. Medulloblastoma
  64. Multiple myeloma
  65. Neuroblastoma
  66. Neuroendocrine tumours of the foregut
  67. Neuroendocrine tumours of the midgut and hindgut
  68. Non-hodgkin lymphoma (children)
  69. Wilms tumour of the kidney